Question

Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016. Medtronic...

Following is the balance sheet for Medtronic PLC for the year ended April 29, 2016.

Medtronic plc
Consolidated Balance Sheets
($ millions) Apr. 29, 2016 Apr. 24, 2015
Current assets
Cash and cash equivalents $3,221 $4,843
Investments 9,758 14,637
Accounts receivable 5,562 5,112
Inventories 3,473 3,463
Tax assets 697 1,335
Prepaid expenses and other current assets 1,234 1,454
Total current assets 23,945 30,844
Property, plant, and equipment, net 4,841 4,699
Goodwill 41,500 40,530
Other intangible assets, net 26,899 28,101
Long-term tax assets 1,383 774
Other assets 1,559 1,737
Total assets $100,127 $106,685
Current liabilities
Short-term borrowings $1,338 $2,434
Accounts payable 1,709 1,610
Accrued compensation 1,712 1,611
Accrued income taxes 566 935
Deferred tax liabilities - 119
Other accrued expenses 2,185 2,464
Total current liabilities 7,510 9,173
Long-term debt 30,247 33,752
Long-term accrued compensation 1,759 1,535
Long-term accrued income taxes 2,903 2,476
Long-term deferred tax liabilities 3,729 4,700
Other long-term liabilities 1,916 1,819
Total liabilities 48,064 53,455
Shareholders’ equity
Ordinary shares - -
Retained earnings 53,931 54,414
Accumulated other comprehensive (loss) (1,868) (1,184)
Total shareholders’ equity 52,063 53,230
Total liabilities and shareholders’ equity $100,127 $106,685

Use the following assumptions to forecast the company’s balance sheet for FY2017.

Forecasted FY2017 net income $5,486

million

Forecasted FY2017 net sales $38,632

million

Accounts receivable 19.3%

of net sales

Inventories 12.0%

of net sales

Tax assets 2.4%

of net sales

Prepaid expenses and other current assets 4.3%

of net sales

Long-term tax assets 4.8%

of net sales

Other assets 5.4%

of net sales

Accounts payable 5.9%

of net sales

Accrued compensation 5.9%

of net sales

Accrued income taxes 2.0%

of net sales

Other accrued expenses 7.6%

of net sales

Long-term accrued income taxes 10.1%

of net sales

Long-term deferred tax liabilities 12.9%

of net sales

Other long-term liabilities 6.6%

of net sales

Investments No change
Goodwill No change
Long-term accrued compensation and retirement benefits No change
Ordinary shares No change
Accumulated other comprehensive (loss) No change
CAPEX 3.6%

of net sales

Depreciation expense 18.9%

of prior year PPE, net

Amortization expense in FY2016 $1,931

million

Current maturities of debt due in FY2017 $1,338

million

Current maturities of debt due in FY2018 $6,176

million

Dividend payout ratio 60.5%
  • Round your answers to the nearest whole number.

  • Do not use negative signs with any of your answers.

Medtronic plc
Forecasted Consolidated Balance Sheet
($ millions) EST. 2017
Current assets
Cash and cash equivalents Answer
Investments Answer
Accounts receivable Answer
Inventories Answer
Tax assets Answer
Prepaid expenses and other current assets Answer
Total current assets Answer
Property, plant, and equipment, net Answer
Goodwill Answer
Other intangible assets, net Answer
Long-term tax assets Answer
Other assets Answer
Total assets Answer
Current liabilities
Short-term borrowings Answer
Accounts payable Answer
Accrued compensation Answer
Accrued income taxes Answer
Other accrued expenses Answer
Total current liabilities Answer
Long-term debt Answer
Long-term accrued compensation Answer
Long-term accrued income taxes Answer
Long-term deferred tax liabilities Answer
Other long-term liabilities Answer
Total liabilities Answer
Shareholders’ equity
Ordinary shares -
Retained earnings Answer
Accumulated other comprehensive (loss) Answer
Total shareholders’ equity Answer
Total liabilities and shareholders’ equity Answer

Homework Answers

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated...
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,499 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,957 Interest expense, net 955 Income...
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC....
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,277 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,735 Interest expense,...
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC....
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,277 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,735 Interest expense,...
Refine Assumptions for PPE Forecast Following are the income statement and balance sheet for Medtronic PLC....
Refine Assumptions for PPE Forecast Following are the income statement and balance sheet for Medtronic PLC. Consolidated Statement of Income ($ millions) For Fiscal Year Ended April 26, 2019 Net sales $30,557 Costs and expenses Cost of products sold 9,155 Research and development expenses 2,330 Selling, general, and administrative expense 10,418 Amortization of intangible assets 1,764 Restructuring charges, net 198 Certain litigation charges, net 166 Other operating expense, net 258 Operating profit (loss) 6,268 Other nonoperating income, net (373) Interest...
Refine Assumptions for Dividend and Retained Earnings Forecast Following are the income statement and balance sheet...
Refine Assumptions for Dividend and Retained Earnings Forecast Following are the income statement and balance sheet for Medtronic PLC. Consolidated Statement of Income ($ millions) For Fiscal Year Ended April 26, 2019 Net sales $30,557 Costs and expenses Cost of products sold 9,155 Research and development expenses 2,330 Selling, general, and administrative expense 10,418 Amortization of intangible assets 1,764 Restructuring charges, net 198 Certain litigation charges, net 166 Other operating expense, net 258 Operating profit (loss) 6,268 Other nonoperating income,...
Analyzing, Forecasting, and Interpreting Both Income Statement and Balance Sheet Following are the income statements and...
Analyzing, Forecasting, and Interpreting Both Income Statement and Balance Sheet Following are the income statements and balance sheets of General Mills, Inc. Income Statement, Fiscal Years Ended ($ millions) May 29, 2011 May 30, 2010 Net Sales $ 14,880.2 $ 14,635.6 Cost of sales 8,926.7 8,835.4 Selling, general and administrative expenses 3,192.0 3,162.7 Divestitures (gain), net (17.4) -- Restructuring, impairment, and other exit costs 4.4 31.4 Operating income 2,774.5 2,606.1 Interest, net 346.3 401.6 Earnings before income tax expense and...
Income Statement and Balance Sheet KRISPY KREME DOUGHNUTS, INC. CONSOLIDATED STATEMENT OF CASH FLOWS Year Ended...
Income Statement and Balance Sheet KRISPY KREME DOUGHNUTS, INC. CONSOLIDATED STATEMENT OF CASH FLOWS Year Ended Feb. 1, 2015 (In thousands, except per share amounts) Revenues $ 383,984 Operating expenses: Direct operating expenses (exclusive of depreciation and amortization shown below) 345,007 General and administrative expenses 23,458 Depreciation and amortization expense 8,709 Impairment charges and lease termination costs 548 Settlement of litigation — (14,930 ) Other operating (income) and expense, net 1,501 Operating income (loss) 4,761 Interest income 331 Interest expense...
Operating Section of Statement of Cash Flows (Indirect Method) Following are the income statement and balance...
Operating Section of Statement of Cash Flows (Indirect Method) Following are the income statement and balance sheet for Nike Inc. for the year ended May 31, 2016, and a forecasted income statement and balance sheet for 2017. Nike Inc. Income Statement For Year Ended May 31 $ millions 2016 actual 2017 Est. Revenues $ 32,376 $ 34,319 Cost of sales 17,405 18,464 Gross profit 14,971 15,855 Demand creation expense 3,278 3,466 Operating overhead expense 7,191 7,619 Total selling and administrative...
My balance sheet does not balance please correct the missing information from trial balance and correct...
My balance sheet does not balance please correct the missing information from trial balance and correct the balance sheet below. Trial Balance 2015 Dr Cr Accounts Payable          999,210 Accounts Receivable        2,943,125 Accrued Liabilities - Other          508,643 Accrued Pension Liabilities          650,216 Accrued Restructuring Charges          126,000 Accrued Salaries, Wages and Commissions          281,364 Accumulated Other Comprehensive Income (Loss)            621,236 Accumulated Depreciation - Property, Plant & Equipment       1,829,634 Accumulated Post-Employment Benefit Obligation (long-term)          802,316 Additional...
Following are the income statement and balance sheet for Cisco Sytems for the year ended July...
Following are the income statement and balance sheet for Cisco Sytems for the year ended July 30, 2016. Cisco Sytems Consolidated Statements of Income Years Ended December ($ millions) July 30, 2016 July 25, 2015 Revenue Product $37,254 $37,750 Service 11,993 11,411 Total revenue 49,247 49,161 Cost of sales Product 14,161 15,377 Service 4,126 4,103 Total cost of sales 18,287 19,480 Gross margin 30,960 29,681 Operating expenses Research and development 6,296 6,207 Sales and marketing 9,619 9,821 General and administrative...